Bioantibody Biotechnology Co., Ltd.

Founded in July 2019 and located in Jiangsu Life Science and Technology Park, a national science and technology business incubator in Nanjing, Nanjing Bai Anti Biotechnology Co., Ltd. is a high-tech enterprise focusing on the research, development, production, and sales of key upstream active raw materials in the field of in vitro diagnostics and biopharmaceuticals.

Based on the original and highly efficient targeted hybridoma cell fusion technology and the supporting cell stabilizing growth factor and high-throughput screening platform, the company has developed nearly 100 kinds of antigens, antibodies, enzymes nucleic acids and other core raw materials. The products are exported to domestic and overseas and have gained wide recognition from customers.2022 end of the year the company obtained nearly 100 million yuan of A round of financing, to accelerate the company's product development and globalization layout.